Ethics in oncology: Consulting for the investment industry

Journal of Clinical Oncology

Volumn 25, Issue 4, 2007, Pages 444-446

  Berlin, Jordan ^a   Bruinooge, Suanna S ^a   Tannock, Ian F ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INVESTMENT; MEDICAL ETHICS; MEDICAL PRACTICE; MEDICAL RESEARCH; ONCOLOGY; PRIORITY JOURNAL; SHORT SURVEY; ARTICLE; CLINICAL TRIAL; COMMERCIAL PHENOMENA; CONFLICT OF INTEREST; CONSULTATION; DRUG INDUSTRY; ETHICS; FORECASTING; HUMAN; PHYSICIAN ATTITUDE;

ANTINEOPLASTIC AGENT;

ANTINEOPLASTIC AGENTS; CLINICAL TRIALS; COMMERCE; CONFLICT OF INTEREST; CONSULTANTS; DRUG INDUSTRY; ETHICS, PROFESSIONAL; FORECASTING; HUMANS; INVESTMENTS; MEDICAL ONCOLOGY; PHYSICIAN'S ROLE;

EID: 33846980465     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.10.3036     Document Type: Short Survey

References (4)

1. Topol EJ, Blumenthal D: Physicians and the investment industry. JAMA 293:2654-2657, 2005
2. Steinbrook R: Wall Street and clinical trials. N Engl J Med 353:1091-1093, 2005
3. Timmerman L, Heath D: Drug researchers leak secrets to Wall Street. The Seattle Times, August 7, 2005
4. American Society of Clinical Oncology: Interactions with the investment industry: Practical and ethical implications. J Clin Oncol 25: 10.1200/JCO.2006.08.9052